N-Terminal pro-B-Type Natriuretic Peptide and Atrial Fibrillation Detection after Ischaemic Stroke or Transient Ischaemic Attack

被引:0
|
作者
Katsas, G.
Yang, J.
Abdul-Rahim, A.
Dawson, J.
Cameron, A.
机构
[1] Univ Glasgow, Sch Cardiovasc & Metab Hlth, Glasgow, Scotland
[2] Univ Liverpool, Liverpool, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:82 / 82
页数:1
相关论文
共 50 条
  • [1] N-terminal pro-B-type natriuretic peptide and the risk of stroke and transient ischaemic attack: the Rotterdam Study
    Portegies, M. L. P.
    Kavousi, M.
    Leening, M. J. G.
    Bos, M. J.
    van den Meiracker, A. H.
    Hofman, A.
    Franco, O. H.
    Koudstaal, P. J.
    Ikram, M. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (04) : 695 - 701
  • [2] Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack
    Okada, Y.
    Shibazaki, K.
    Kimura, K.
    Iguchi, Y.
    Miki, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (02) : 326 - 331
  • [3] Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke
    Garcia-Carmona, J. A.
    Conesa-Garcia, E.
    Vidal-Mena, D.
    Gonzalez-Morales, M.
    Ramos-Arenas, V.
    Sanchez-Vizcaino-Buendia, C.
    Soria-Torrecillas, J. J.
    Perez-Vicente, J. A.
    Garcia-de-Guadiana-Romualdo, L.
    NEUROLOGIA, 2024, 39 (06): : 496 - 504
  • [4] Usefulness of N-terminal pro-B-type natriuretic peptide levels for stroke prediction in anticoagulated patients with atrial fibrillation
    Roldan, V.
    Marin, F.
    Vilchez, J. A.
    Dominguez, V.
    Puche, C.
    Romera, M.
    Manzano-Fernandez, S.
    Vicente, V.
    Valdes, M.
    Lip, G. Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 745 - 745
  • [5] Comparison of the Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Death and Cardiovascular Events: Superiority of N-Terminal Pro-B-Type Natriuretic Peptide
    McKie, Paul
    Cataliotti, Alessandro
    Sangaralingham, S. J.
    Ichiki, Tomoko
    Redfield, Margaret
    Chen, Horng
    Rodeheffer, Richard
    Burnett, John
    CIRCULATION, 2010, 122 (21)
  • [6] N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy
    Krackhardt, Florian
    Duengen, Hans-Dirk
    Trippel, Tobias Daniel
    Inkrot, Simone
    Tscholl, Verena
    Schlattmann, Peter
    Kehrt, Kathrin
    Haverkamp, Wilhelm
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (23-24) : 738 - 742
  • [7] Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation
    Roldan, Vanessa
    Antonio Vilchez, Juan
    Manzano-Fernandez, Sergio
    Jover, Eva
    Galvez, Josefa
    Puche, Carmen M.
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    Marin, Francisco
    STROKE, 2014, 45 (03) : 696 - 701
  • [8] The utility of N-terminal pro-b-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
    Shelton, RJ
    Clark, AL
    Goode, K
    Rigby, AS
    Velavan, P
    Tin, LL
    Windram, J
    Loh, H
    Cleland, JG
    CIRCULATION, 2005, 112 (17) : U662 - U662
  • [9] N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
    Ezekowitz, Justin A.
    O'Connor, Christopher M.
    Troughton, Richard W.
    Alemayehu, Wendimagegn G.
    Westerhout, Cynthia M.
    Voors, Adriaan A.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Emdin, Michele
    Patel, Mahesh J.
    Pieske, Burkert
    Roessig, Lothar
    Hernandez, Adrian F.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2020, 8 (11) : 931 - 939
  • [10] N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD
    Sasaki, Takaya
    Oishi, Emi
    Nagata, Takuya
    Sakata, Satoko
    Chen, Sanmei
    Furuta, Yoshihiko
    Honda, Takanori
    Yoshida, Daigo
    Hata, Jun
    Tsuboi, Nobuo
    Kitazono, Takanari
    Yokoo, Takashi
    Ninomiya, Toshiharu
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 976 - 985